AzTrials
AzTrials

Brain InjuriesPhase 4NCT01214070

Functional Vision in TBI

A Phase 4 study testing Vision Restoration Therapy, NVT Eye Scanning Therapy and Eccentric Viewing Training in people with Brain Injuries and Visually Impaired Persons, run by VA Office of Research and Development at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The objective of this study is to test functional vision outcome measures that reflect the loss in everyday life tasks that require vision and that are sensitive to changes after a course of vision rehabilitation in Veterans/participants with TBI. Read more about this study

Who is it for?
Ages 20 to 79 years
Conditions the study is for
Brain Injuries, Visually Impaired Persons
What is being tested?
Vision Restoration Therapy, NVT Eye Scanning Therapy and Eccentric Viewing Training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
110 participants
Where
1 siteUnited States
Study dates
1 Jun 2012to 21 Nov 2013
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 79 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • TBI (any form)
  • Hemianopic Visual Field Loss
  • Stable fixation
  • 1.0 logMAR or better Reading Acuity
  • 20 words per minute or better reading rate

Who cannot join

  • Visual Neglect
  • medical conditions that prevent sitting for 30 minutes or following instructions

Trial locations and contacts

1 site in 1 country.

United States1 site
  • VA Palo Alto Health Care System

    Palo Alto, California, 94304-1290

Other trials in United States

About this study

Official title: Functional Vision Consequences of Rehabilitation for TBI Vision Loss

The objective of this study is to test functional vision outcome measures that reflect the loss in everyday life tasks that require vision and that are sensitive to changes after a course of vision rehabilitation in Veterans/participants with TBI.

Read the detailed description

Traumatic brain injury (TBI) can cause vision loss because of diffuse or focal neuronal injury. Vision can be compromised because of local injury to one or both optic nerves, diffuse brain injury, and/or limitation in eye movements because of dysfunction of cranial nerves. These typical injuries may compromise any of the neural pathways that subserve afferent or efferent visual function. Self-reports of vision loss include diplopia, visual field loss, light sensitivity, reading problems and contrast sensitivity (color and luminance) loss. This project will pursue the following aims: 1) Identify the relationship between functional vision loss in everyday vision tasks (reading, visual search, way finding) and the characteristics of potential visual impairment (visual acuity, contrast sensitivity, visual fields, stereoacuity, eye movement disorders) associated with TBI; and 2) Determine the ability of the vision rehabilitation interventions (both monotherapy and combination therapy) to improve functional vision outcome measures that reflect everyday visual tasks. The vision rehabilitation interventions incorporated into this study will be Vision Restoration Therapy, NVT Eye Scanning Therapy, and standard Eccentric Viewing Training. These therapies are rehabilitative interventions prescribed for Veterans in Polytrauma Rehabilitation Centers, Blind Rehabilitation Centers, and advocated for VA Medical Center TBI clinics.

Being tested
Vision Restoration Therapy, NVT Eye Scanning Therapy, Eccentric Viewing Training, Sham
Keywords
Visual Perception, Vision, Ocular, Neuronal Plasticity
Medical subject headings
Brain Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vision Restoration TherapyOther

    Therapy that enhances the neuronal plasticity of the visual system

  • NVT Eye Scanning TherapyBehavioural

    Therapy that trains eye and head scanning into the blind hemianoptic visual field

  • Eccentric Viewing TrainingBehavioural

    Therapy that trains the person to compensate for visual field loss by learning to move the visual field loss to the position that is least likely to impact the current visual task

  • ShamBehavioural

    Therapy that encourages subjects to do daily visual tasks at home while having no training or intended intervention benefit

Study groups in NCT01214070
Study groupRoleWhat they receive
Arm 1Active comparatorGroup 1 - Combination Treatment
Receives: Other: Vision Restoration Therapy; Behavioral: NVT Eye Scanning Therapy
Arm 2Active comparatorGroup 2 - Combination Treatment
Receives: Behavioral: Eccentric Viewing Training
Arm 3Active comparatorGroup 3 - Combination Treatment
Receives: Other: Vision Restoration Therapy; Behavioral: NVT Eye Scanning Therapy
Arm 4Active comparatorGroup 4 - Combination Treatment
Receives: Behavioral: Eccentric Viewing Training
Arm 5Active comparatorGroup 5 - Monotherapy Treatment
Receives: Other: Vision Restoration Therapy; Behavioral: Sham
Arm 6Active comparatorGroup 6 - Monotherapy Treatment
Receives: Behavioral: Eccentric Viewing Training; Behavioral: Sham
Arm 7Active comparatorGroup 7 - Monotherapy Treatment
Receives: Behavioral: NVT Eye Scanning Therapy; Behavioral: Sham

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dynamic Visual Field

    Measured: Baseline

Secondary outcomes (8)
  1. Dynamic Visual Field

    Measured: After First Therapy / Before Second Therapy (Average time is 4.5 months)

  2. Dynamic Visual Field

    Measured: After Second Therapy (Average Time is 9 months)

  3. Reading Rate and Accuracy

    Measured: Baseline

  4. Reading Rate

    Measured: After First Therapy / Before Second Therapy (average time is 4.5 months)

  5. Reading Rate and Accuracy

    Measured: After Second Therapy (average time is 9 months)

  6. Visual Search Accuracy and Timing

    Measured: Baseline

  7. Visual Search Accuracy and Timing

    Measured: After First Therapy / Before Second Therapy (average time is 4.5 months)

  8. Visual Search Accuracy and Timing

    Measured: After Second Therapy (average time is 9 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Oct 2010 (estimated)
  2. Study start1 Jun 2012
  3. Primary completion21 Nov 2013
  4. Study completion21 Nov 2013

Why it stopped: Administrative Closure

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01214070
Sponsor's protocol ID
C6687-R
Status last verified
Jun 2017
First submitted
14 Sep 2010
Last updated
16 Jun 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Vision Restoration Therapy, NVT Eye Scanning Therapy and Eccentric Viewing Training in people with Brain Injuries and Visually Impaired Persons, run by VA Office of Research and Development at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 16 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was stopped early (reason given: Administrative Closure). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dynamic Visual Field (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in